U.S. Food Stock News

Arrowhead Pharmaceuticals has released two-year open-label extension data showing that investigational plozasiran delivered durable triglyceride reductions and a consistent safety profile in patients with severe and mixed hypertriglyceridemia, with no adjudicated acute pancreatitis events reported. The results underscore plozasiran’s potential to address a patient population with few effective long-term options by achieving triglyceride levels below guideline risk thresholds in most...

Harley-Davidson (HOG) has moved back into focus after announcing global workforce reductions and outlining plans to tackle weaker demand, higher tariff costs, and recent revenue and profit declines. See our latest analysis for Harley-Davidson. Harley-Davidson’s recent workforce cuts and weaker results have come alongside a 7-day share price return of 10.75%. However, the 1-year total shareholder return of 20.05% and 5-year total shareholder return of 45.95% show longer term momentum has...

Definium Therapeutics (DFTX) is back in focus after recent communications around its April Investor & Analyst Day, where management plans to spotlight late stage DT120 ODT data timelines in major depressive disorder and generalized anxiety disorder. See our latest analysis for Definium Therapeutics. Definium Therapeutics’ recent Investor & Analyst Day spotlight and earlier name change have arrived after a strong run, with a 90 day share price return of 36.91% and a very large 3 year total...

In March 2026, Aspect announced it had formalized a partnership with Five9, integrating Five9’s real-time and historical interaction data into Aspect Intelligence to improve forecasting, scheduling, and workforce optimization for enterprise and mid-market contact centers. This collaboration highlights how embedding advanced workforce management into Five9’s cloud contact center platform can help organizations align live customer demand, staffing levels, and operational efficiency within a...

Navan (NAVN) is back in focus after its latest earnings report, where strong Q4 and full year revenue, earlier than planned free cash flow positivity, and AI driven products like Navan Edge caught investor attention. See our latest analysis for Navan. The latest earnings release and upbeat guidance have pulled fresh attention to Navan, even as the share price has been volatile. A 7 day share price return of 37.7% and a year to date share price return decline of 24.9% suggest that short term...

Why Murphy USA (MUSA) Is Getting Attention Now Murphy USA (MUSA) has drawn fresh interest after a strong month, with the stock returning about 32% over that period. This move has prompted investors to reassess the fuel retailer’s recent performance and valuation. See our latest analysis for Murphy USA. The recent 31.8% 30 day share price return adds to a 24.9% year to date share price gain and a 257.27% five year total shareholder return, which points to strong long term momentum that has...

If you are wondering whether Barrick Mining's current share price still offers value, this article walks through the key numbers so you can judge the stock's appeal with more confidence. Recently, the stock closed at US$38.59, with returns of 3.9% over the last 7 days, a 22.5% decline over 30 days, a 12.5% decline year to date, and 106.4% over 1 year, with 123.0% over 3 years and 119.3% over 5 years. Recent news coverage has focused on Barrick Mining's position within the broader materials...

If you are wondering whether Accenture at around US$192.60 still justifies your attention, or if the current price already reflects its quality, this article focuses squarely on what you are paying versus what you might be getting. The stock has had a mixed run, with a 3.7% decline over the last 7 days, a 0.6% gain over 30 days, a 25.9% decline year to date and a 35.3% decline over the last year. This naturally raises questions about how the market is reassessing its risk and...

Pfizer (NYSE:PFE) reported positive Phase 2 results for atirmociclib in metastatic breast cancer. The company announced favorable Phase 3 TALAPRO-3 data for TALZENNA in prostate cancer. Both readouts highlight progress in Pfizer's oncology pipeline and broader R&D efforts. For investors tracking Pfizer, the latest oncology readouts add fresh context to a business best known recently for its vaccines and antiviral treatments. Cancer medicines are a key focus area for large pharma companies,...

AXT (AXTI) is drawing fresh attention after March 2026 insider sales, with Director Jesse Chen cutting his direct stake sharply while CEO Morris S. Young trimmed his position more modestly through indirect transactions. See our latest analysis for AXT. Those insider sales come after a sharp share price run, with AXT’s 30 day share price return of 47.99% and 90 day share price return of 294.47%, alongside a very large 1 year total shareholder return that signals powerful momentum rather than...

Belden (NYSE:BDC) has been named to Newsweek’s America’s Most Responsible Companies list for a third consecutive year. The company reports achieving key sustainability milestones, including surpassing certain greenhouse gas reduction targets. Belden has expanded its Great Place to Work certification across more global locations. The company plans to introduce new long-term environmental, social, and governance goals in Spring 2026. Belden, listed on the NYSE under the ticker BDC, supplies...

Activist investor Irenic Capital Management has publicly urged Teleflex (NYSE:TFX) to engage with acquisition offers. Irenic is pressing the Board to form a Strategic Review sub committee with new independent directors and consider all options. The investor is also calling for potential board changes, including the appointment of a new Chair, citing concerns about value destruction and leadership gaps. Teleflex, a medical technology company focused on single use devices for critical care...

Wondering if National Fuel Gas at around US$95.29 is still reasonably priced after a strong run, or if you might be turning up late to the story. The stock has returned 3.9% over the past week, 7.7% over the last month, 16.1% year to date, and 24.0% over the past year. This naturally raises questions about how much value is already reflected in the price. Recent coverage has focused on National Fuel Gas as a vertically integrated gas utility and energy company, with attention on how it...

Disneyland Resort is temporarily closing the Pirates of the Caribbean attraction and the adjacent Blue Bayou Restaurant for refurbishment. The closures are part of ongoing upgrades to core park offerings at Walt Disney's Parks and Experiences division (NYSE:DIS). These works focus on refreshing legacy assets that are central to guest demand and brand identity. For anyone tracking NYSE:DIS, park refurbishments like this are a reminder that Disney continues to put money and attention into...

Earlier this week, Truist upgraded Airbnb to Hold from Sell after raising its 2026 adjusted EBITDA and earnings estimates, following Q4 results showing 16% year-over-year Gross Booking Value growth and Q1 2026 revenue guidance of 14%–16% growth. The upgrade underscores how Airbnb’s recent margin pressure was tied to spending on hotel partnerships and new services that Truist now expects to support improved profitability. Next, we’ll examine how Truist’s more optimistic view on Airbnb’s...

Setting the Scene for Expedia Group Stock Expedia Group (EXPE) has drawn attention recently after a mix of short term share price swings and longer term returns that look very different depending on the timeframe investors focus on. See our latest analysis for Expedia Group. The recent 1 day and 7 day share price declines sit against a 30 day share price return of 10.83% and a 1 year total shareholder return of 35.42%. This suggests shorter term momentum has faded while longer term...

Wondering whether Cleveland-Cliffs at a last close of US$8.11 offers value or a value trap? This breakdown will help you frame the price against what the business may be worth. The stock has recently shown mixed performance, with a 3.7% gain over the last 7 days but declines of 24.8% over 30 days, 40.4% year to date, and 4.8% over the past year. These moves sit against a longer track record that shows 55.8% and 58.2% declines over the past 3 and 5 years respectively. This can influence how...

Why Par Pacific Holdings Is on Investor Radars Par Pacific Holdings (PARR) has drawn fresh attention after a strong recent run, with the stock showing double digit returns over the past month and the past 3 months. This performance is prompting closer scrutiny of its underlying business. See our latest analysis for Par Pacific Holdings. At a share price of $65.67, the stock has moved sharply in recent months, with an 83.33% year to date share price return and a very large 1 year total...

Summit Therapeutics presented new Phase III data on ivonescimab at the 2026 European Lung Cancer Congress in EGFR mutated NSCLC. The data highlighted improved intracranial progression free survival, including in patients with brain metastases. The company has submitted a Biologics License Application to the FDA, with a PDUFA decision date set for November. Summit Therapeutics, trading as NasdaqGM:SMMT, is drawing attention after sharing these late stage results alongside a confirmed FDA...

California Water Service Group (CWT) is back on watch after recent share price moves, with the stock showing mixed returns over the past year as investors reassess this regulated water utility. See our latest analysis for California Water Service Group. At a share price of $45.01, California Water Service Group has recently seen a 7 day share price return of 2.51% but the 1 year total shareholder return is a decline of 4.2%. This suggests that recent momentum contrasts with weaker longer term...

Recent share performance and business profile Rithm Capital (RITM) has drawn attention after a recent 1 day share price decline of 1.8%, following gains of 4.2% over the past week and negative returns over the past month and past 3 months. The company operates as an asset manager focused on real estate, credit, and financial services in the United States, with a market value of about US$5.2b and a last close of US$9.14 per share. See our latest analysis for Rithm Capital. That recent 1 day...

If you are wondering whether Solaris Energy Infrastructure at US$57.83 is still attractively priced after its run, this section is designed to help you frame that question clearly. The stock has seen a 6.4% decline over the past week, a 4.7% gain over the last 30 days, a 15.1% gain year to date, and a 156.2% gain over the last year, which may signal shifting views on both its potential and its risks. Recent attention on the company has focused on its role in energy infrastructure and how...

Earlier this month, OpenText released a global report with the Ponemon Institute on managing risks and optimizing the value of AI, generative AI, and agentic AI, highlighting that many enterprises have adopted these tools without fully developed security and governance frameworks. The study’s finding that only a small minority of enterprises fully embed AI into cybersecurity and risk assessment underlines a widening gap between AI deployment and risk management that could influence how...

Churchill Downs (CHDN) is back in focus after recent share price moves, with the stock closing at US$84.52 and showing negative returns over the past month, the past three months, and the past year. See our latest analysis for Churchill Downs. The recent 1 day share price return of 3.48% decline caps a tougher patch for Churchill Downs, with the 30 day share price return of 12.09% decline and 1 year total shareholder return of 23.72% decline, which together point to fading momentum despite...